Adaptive optics scanning laser ophthalmoscope-based microperimetry: establishing
基于自适应光学扫描激光检眼镜的微视野测量:建立
基本信息
- 批准号:8443279
- 负责人:
- 金额:$ 10.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-12-01 至 2015-11-30
- 项目状态:已结题
- 来源:
- 关键词:AdolescenceAdvanced DevelopmentBlindnessCessation of lifeCiliary Neurotrophic FactorClinical TrialsCustomDark AdaptationDatabasesDetectionDevelopment PlansDimensionsDiseaseDisease ProgressionEvaluationEyeFunctional ImagingGoalsHealthHumanImageInborn Genetic DiseasesIndividualLasersLeftLifeLongitudinal StudiesLow PrevalenceMeasuresMediatingMentorsMentorshipMethodsMicroscopicModelingNight BlindnessOphthalmoscopesOphthalmoscopyOpticsOutcome MeasurePatientsPeripheralPhotoreceptorsPositioning AttributePrevalencePsychophysicsRelative (related person)ResearchResearch PersonnelResolutionRetinaRetinalRetinal ConeRetinal DegenerationRetinal DiseasesRetinitis PigmentosaScanningScientistSpeedStagingStructureStructure-Activity RelationshipSystemTechnologyTestingTimeUnited StatesUsher SyndromeVertebrate PhotoreceptorsVisionVisualVisual AcuityVisual Fieldsadaptive opticsaustinbasecareercareer developmentclinically significantcostdensitydesigneffective therapyexperiencefunctional outcomesfunctional statusimaging modalityin vivoinherited retinal degenerationinterestnew technologynovelnovel therapeutic interventionphotoreceptor degenerationpreventpublic health relevanceretinotopicskillstherapy designtooltreatment effectvisual performancevisual stimulusyoung adult
项目摘要
DESCRIPTION (provided by applicant): The adaptive optics scanning laser ophthalmoscope (AOSLO) is a custom-built tool used to overcome the limitations imposed by the eye's imperfect optics, allowing the researcher to noninvasively image individual cone photoreceptors in the living human retina. In addition to its capacity for high-resolution imaging, AOSLO can be employed to conduct aberration-free measures of visual sensitivity on a microscopic scale. Incorporating high-speed eye tracking into the AOSLO allows the visual stimulus to be targeted to retinal regions of interest with single cone precision. As a result, the AOSLO affords the best possible level of control over the visual stimulus, allowing highly precise correlations between retinal structure and function to be established. The aim of this project is to develop tools-namely, AOSLO-based microperimetry-to enhance our understanding of the high-resolution structural information available in AOSLO images, and to apply these tools to the longitudinal study of structure-function relationships in patients with inherited retinal degenerations. AOSLO-based retinal imaging has shown potential as a highly-sensitive measure for disease progression in clinical trials evaluating outer retinal degenerations and their treatments A recent
study from our group that included AOSLO imaging in a subset of three retinitis pigmentosa (RP) patients demonstrated that treatment with ciliary neurotrophic factor (CNTF) prevents photoreceptor loss relative to untreated eyes; however, the standard functional outcome measures used in the trial indicated no significant difference in visual performance between treated and untreated eyes. Because of its unprecedented ability to test visual sensitivity with high retinotopic precision, AOSLO-based microperimetry is uniquely suited to better elucidate the functional status of these CNTF-preserved cones. The proposed research aims to establish AOSLO-based microperimetry as a means to measure visual function on a microscopic scale. Once our optical set-up is optimized (Aim 1) and a normative database of AOSLO-based microperimetry values is established (Aim 2), we plan to apply these tools to examine the relationship between high-resolution retinal structure and function in patients with RP, including those undergoing CNTF treatment (Aims 3 and 4). The proposed project encompasses aspects of my previous research experiences, and has been designed to leave me with a unique set of skills that will put me on track to achieve my long-term goal of becoming an independent clinician-scientist conducting meaningful patient-based research. My mentor, Austin Roorda, offers expertise in developing advanced ophthalmic imaging systems, and my co-mentor, Jacque Duncan, brings experience in conducting patient-based research in patients with retinal degenerations. Their mentorship, combined with my career development plan and the support and facilities provided by UC Berkeley and UCSF, will position me to succeed in completing this project and achieving my career objectives.
描述(由申请人提供):自适应光学扫描激光检眼镜(AOSLO)是一种定制工具,用于克服眼睛不完美光学所带来的限制,使研究人员能够对活体人类视网膜中的单个锥体光感受器进行非侵入性成像。除了其高分辨率成像能力外,AOSLO还可用于在微观尺度上进行无像差的视觉灵敏度测量。将高速眼动追踪功能集成到AOSLO中,可使视觉刺激以单锥精确度瞄准视网膜感兴趣区域。因此,AOSLO提供了对视觉刺激的最佳控制水平,允许建立视网膜结构和功能之间的高度精确的相关性。该项目的目的是开发工具,即AOSLO为基础的微周长,以提高我们的理解的高分辨率结构信息AOSLO图像,并应用这些工具的纵向研究结构功能关系的患者遗传性视网膜变性。 基于AOSLO的视网膜成像在评估外部视网膜变性及其治疗的临床试验中显示出作为疾病进展的高灵敏度测量的潜力。
我们小组的一项研究包括对三名视网膜色素变性(RP)患者进行AOSLO成像,该研究表明,与未治疗的眼睛相比,睫状神经营养因子(CNTF)治疗可预防感光细胞损失;然而,试验中使用的标准功能结果测量表明,治疗和未治疗的眼睛之间的视觉表现无显著差异。由于其前所未有的能力,测试视觉灵敏度与高视网膜定位精度,AOSLO为基础的微视野是唯一适合于更好地阐明这些CNTF保存锥的功能状态。 拟议的研究旨在建立基于AOSLO的微视野作为在微观尺度上测量视觉功能的手段。一旦我们的光学设置被优化(目标1),并建立了基于AOSLO的微视野值的规范数据库(目标2),我们计划应用这些工具来检查RP患者的高分辨率视网膜结构和功能之间的关系,包括那些接受CNTF治疗的患者(目标3和4)。 拟议的项目包括我以前的研究经验的各个方面,并已被设计为留给我一套独特的技能,这将使我走上正轨,以实现我的长期目标,成为一个独立的临床医生,科学家进行有意义的患者为基础的研究。我的导师Austin Roorda提供了开发先进眼科成像系统的专业知识,我的共同导师Jacque邓肯带来了对视网膜变性患者进行基于患者的研究的经验。他们的指导,加上我的职业发展计划,以及加州大学伯克利分校和加州大学旧金山分校提供的支持和设施,将使我能够成功完成这个项目,实现我的职业目标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
William Scott Tuten其他文献
William Scott Tuten的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('William Scott Tuten', 18)}}的其他基金
Adaptive optics scanning laser ophthalmoscope-based microperimetry: establishing
基于自适应光学扫描激光检眼镜的微视野测量:建立
- 批准号:
8788932 - 财政年份:2012
- 资助金额:
$ 10.99万 - 项目类别:
相似海外基金
ADVANCED DEVELOPMENT OF LQ A LIPOSOME-BASED SAPONIN-CONTAINING ADJUVANT FOR USE IN PANSARBECOVIRUS VACCINES
用于 Pansarbecovirus 疫苗的 LQ A 脂质体含皂苷佐剂的先进开发
- 批准号:
10935820 - 财政年份:2023
- 资助金额:
$ 10.99万 - 项目类别:
ADVANCED DEVELOPMENT OF BBT-059 AS A RADIATION MEDICAL COUNTERMEASURE FOR DOSING UP TO 48H POST EXPOSURE"
BBT-059 的先进开发,作为辐射医学对策,可在暴露后 48 小时内进行给药”
- 批准号:
10932514 - 财政年份:2023
- 资助金额:
$ 10.99万 - 项目类别:
Advanced Development of a Combined Shigella-ETEC Vaccine
志贺氏菌-ETEC 联合疫苗的先进开发
- 批准号:
10704845 - 财政年份:2023
- 资助金额:
$ 10.99万 - 项目类别:
Advanced development of composite gene delivery and CAR engineering systems
复合基因递送和CAR工程系统的先进开发
- 批准号:
10709085 - 财政年份:2023
- 资助金额:
$ 10.99万 - 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
- 批准号:
10409385 - 财政年份:2022
- 资助金额:
$ 10.99万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
- 批准号:
10710595 - 财政年份:2022
- 资助金额:
$ 10.99万 - 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
- 批准号:
10630975 - 财政年份:2022
- 资助金额:
$ 10.99万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE CANDIDATE FOR STAPHYLOCOCCUS AUREUS INFECTION
金黄色葡萄球菌感染候选疫苗的高级开发
- 批准号:
10710588 - 财政年份:2022
- 资助金额:
$ 10.99万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
- 批准号:
10788051 - 财政年份:2022
- 资助金额:
$ 10.99万 - 项目类别:














{{item.name}}会员




